{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:49:15Z","timestamp":1778395755461,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T00:00:00Z","timestamp":1115078400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:p> <jats:italic>Quinidine, a class I antiarrhythmic agent with blocking property of transient outward current, is a possible candidate for the suppression of ventricular fibrillation in patients with Brugada syndrome; although there is a concern that its ability to these effects may be proarrhythmic. Therefore, we evaluated the effect of quinidine sulfate on ST\u2010segment elevation in Brugada syndrome. In 8 patients with Brugada syndrome, the magnitude of ST\u2010elevation at the J\u2010point (ST<jats:sup>J<\/jats:sup>), and the ST\u2010segment configuration in leads V1\u2013V3, were compared before and on day 2 after the initiation of quinidine administration. In 3 patients, quinidine attenuated ST<jats:sup>J<\/jats:sup> by \u22650.1 mV. Of these 3 patients, ST\u2010segment elevation was normalized in 2 patients, while the ST\u2010segment configuration was unchanged in another. In another 3 patients, quinidine augmented ST<jats:sup>J<\/jats:sup> by \u22650.1 mV without any change of ST\u2010segment configuration, and the augmentation was returned to baseline after the discontinuation of quinidine. Quinidine exhibited no effect on the ST\u2010segment in the remaining 2 patients. The favorable effects of quinidine on the ST\u2010segment tended to be more pronounced in patients with prominent ST\u2010elevation at baseline. In 1 patient, quinidine was effective in eliminating both ST\u2010segment elevation and repetitive tachyarrhythmia episodes. In conclusion, the effects of quinidine on ST\u2010segment elevation were variable. Quinidine may potentially augment the ST\u2010segment elevation in some patients with Brugada syndrome.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2005.09494.x","type":"journal-article","created":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T08:59:42Z","timestamp":1115110782000},"page":"372-377","source":"Crossref","is-referenced-by-count":12,"title":["Variable Electrocardiographic Effects of Short\u2010Term Quinidine Sulfate Administration in Brugada Syndrome"],"prefix":"10.1111","volume":"28","author":[{"given":"HIROSHI","family":"WATANABE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAOMI","family":"CHINUSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"WASHIZUKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROTAKA","family":"SUGIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"HIRONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SATORU","family":"KOMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIO","family":"HOSAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAYUKI","family":"YAMAURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASUTAKA","family":"TANABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROSHI","family":"FURUSHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SATORU","family":"FUJITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIFUSA","family":"AIZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,5,3]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90253-J"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2461"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1660"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2824"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2002.01634.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.12.046"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143159.30585.90"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1999.tb00183.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2000.01277.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2001.01420.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2004.00537.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2002.3382"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01197-4"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.85.2.589"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1987.253.3.H704"},{"key":"e_1_2_7_17_2","unstructured":"MarrshallSS.Class I antiarrhythmic drugs: Quinidine procainamide disopyramide lidocaine mexiletine tocainide pheytoin moricizine flecainide propafenone.2000."},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.47.6.855"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/32675"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc0602.103618"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1099-5129(03)00085-0"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01962-9"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00505-X"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2005.09494.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2005.09494.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T19:59:31Z","timestamp":1697313571000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2005.09494.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.1540-8159.2005.09494.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2005.09494.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}